115 related articles for article (PubMed ID: 6144380)
1. Cetamolol: a new cardioselective beta-adrenoceptor blocking agent without membrane-stabilizing activity.
Beaulieu G; Jaramillo J; Cummings JR
Can J Physiol Pharmacol; 1984 Mar; 62(3):302-8. PubMed ID: 6144380
[TBL] [Abstract][Full Text] [Related]
2. Cetamolol: cardiovascular effects of a new cardioselective beta-adrenoceptor blocker possessing partial agonistic activity and lacking membrane-stabilizing activity.
Beaulieu G; Grimes D; Muirhead C; Oshiro G
Can J Physiol Pharmacol; 1984 Jun; 62(6):610-6. PubMed ID: 6146394
[TBL] [Abstract][Full Text] [Related]
3. In vitro studies on cetamolol, a new potent cardioselective beta-adrenoceptor blocking agent with intrinsic sympathomimetic activity.
Grimes D; Stern M; Wojdan A; Cummings JR
Can J Physiol Pharmacol; 1983 Oct; 61(10):1109-15. PubMed ID: 6139156
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of cetamolol and atenolol on epinephrine- and isoproterenol-induced hypokalemia in anesthetized dogs.
Klein M; Stupienski RF; Nettler S; Smith T; Oshiro G
J Cardiovasc Pharmacol; 1989 Jan; 13(1):118-24. PubMed ID: 2468922
[TBL] [Abstract][Full Text] [Related]
5. Cardioselectivity of cetamolol compared with atenolol and nadolol.
Klausner MA; Ventura DF; Coelho J; Mullane JF; Irwin C; Hitzenberger G; Magometschnigg D; Kaik G; Garg DC; Weidler DJ
J Clin Pharmacol; 1988 Jun; 28(6):495-504. PubMed ID: 2901435
[TBL] [Abstract][Full Text] [Related]
6. The influence of the intrinsic sympathomimetic activity of beta-adrenoceptor antagonists on haemodynamic effects in anaesthetized dogs.
Wale JL; Austin M; Conway J; Reeves M
Clin Exp Pharmacol Physiol; 1979; 6(1):11-9. PubMed ID: 32981
[TBL] [Abstract][Full Text] [Related]
7. Anti-arrhythmic action of nadolol, a beta-adrenergic receptor blocking agent.
Evans DB; Peschka MT; Lee RJ; Laffan RJ
Eur J Pharmacol; 1976 Jan; 35(1):17-27. PubMed ID: 3420
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of the acute effects of cetamolol (AI-27,303), atenolol, propranolol, and dexpropranolol on blood pressure, sympathetic nerve and ganglion activity of cats.
Jaramillo J
Can J Physiol Pharmacol; 1983 Jul; 61(7):693-8. PubMed ID: 6137273
[TBL] [Abstract][Full Text] [Related]
9. The effect of beta-adrenoceptor blocking agents, with differing ancillary properties, on the arrhythmias resulting from acute coronary artery ligation in anaesthetized rats.
Campbell CA; Parratt JR
Br J Pharmacol; 1983 Aug; 79(4):939-46. PubMed ID: 6140049
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].
Hara Y; Sato E; Miyagishi A; Aono S; Nakatani H
Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):707-20. PubMed ID: 94296
[TBL] [Abstract][Full Text] [Related]
11. Contrastive effects of prostaglandin F2 alpha on normal cardiac rhythm and ouabain-induced cardiac arrhythmias in cats: possible neural basis.
Rao TS; Seth SD; Manchanda SC; Nayar U
Arch Int Pharmacodyn Ther; 1989; 302():128-44. PubMed ID: 2636814
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of beta-adrenoceptor blockade with cetamolol.
Coelho J; Schnelle K; Joubert L; Ventura D; Mullane J
Br J Clin Pharmacol; 1985 Apr; 19(4):411-6. PubMed ID: 2859872
[TBL] [Abstract][Full Text] [Related]
13. [Atenolol, its cardioselective property for adrenergic beta-receptor blocking action and effect on the cardiac function (author's transl)].
Kanno M; Nakaya H; Hattori Y; Izumi T; Nishimura T; Sakai K; Abiko Y
Nihon Yakurigaku Zasshi; 1980 Oct; 76(7):621-32. PubMed ID: 6111522
[TBL] [Abstract][Full Text] [Related]
14. Beta-adrenoceptor blockade and atrio-ventricular conduction in dogs. Role of intrinsic sympathomimetic activity.
Giudicelli JF; Lhoste F
Br J Clin Pharmacol; 1982; 13(Suppl 2):167S-174S. PubMed ID: 6125166
[TBL] [Abstract][Full Text] [Related]
15. Studies on the stereoisomers of beta-adrenoceptor antagonists in conscious A-V blocked dogs.
Boucher M; Duchêne-Marullaz P; Moundanga JL
Br J Pharmacol; 1986 Sep; 89(1):119-27. PubMed ID: 2879587
[TBL] [Abstract][Full Text] [Related]
16. Role of vagus in the antagonism of ouabain induced arrhythmias in dogs by beta-adrenoceptor antagonists and related drugs.
Alkondon M; Ray A; Sen P
J Pharm Pharmacol; 1984 Oct; 36(10):702-4. PubMed ID: 6150094
[TBL] [Abstract][Full Text] [Related]
17. Effects of tiprenolol, practolol and propranolol on experimental ventricular tachyarrhythmias.
Allen JD; Shanks RG
Br J Pharmacol; 1974 Jun; 51(2):179-85. PubMed ID: 4155971
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.
Farmer JB; Kennedy I; Levy GP; Marshall RJ
Br J Pharmacol; 1972 Aug; 45(4):660-75. PubMed ID: 4404413
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological properties of diacetolol (M & B 16,942), a major metabolite of acebutolol.
Basil B; Jordan R
Eur J Pharmacol; 1982 May; 80(1):47-56. PubMed ID: 6124437
[TBL] [Abstract][Full Text] [Related]
20. A study of the relationship between cardiac beta-adrenoceptor blockade and intrinsic sympathomimetic activity in rats depleted of catecholamines.
Bilski A; Robertson HH; Wale JL
Clin Exp Pharmacol Physiol; 1979; 6(1):1-9. PubMed ID: 32980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
